The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.
| Image |  |
|---|---|
| Description | scientific article published on 05 July 2012 |
| Author/s |
author: Atanasio Pandiella Jesús San Miguel Mercedes Garayoa Enrique M Ocio |
| Publication date | July 5, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |